APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Aesthetics

Aesthetic medicine is an extensively broad term for specialties that focus on improving cosmetic appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, skin discoloration, and spider veins. Traditionally, aesthetic medicine includes dermatology, oral and maxillofacial surgery, reconstructive surgery and plastic surgery. Aesthetic medicine includes both surgical procedures (liposuction, facelifts, breast implants, Radio frequency ablation) and non-surgical procedures (radio frequency skin tightening, non-surgical liposuction, chemical peel, high-intensity focused electromagnetic field, radio frequency fat removal), and practitioners may utilize a combination of both.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Aesthetic medicine is an extensively broad term for specialties that focus on improving cosmetic appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, skin discoloration, and spider veins. Traditionally, aesthetic medicine includes dermatology, oral and maxillofacial surgery, reconstructive surgery and plastic surgery. Aesthetic medicine includes both surgical procedures (liposuction, facelifts, breast implants, Radio frequency ablation) and non-surgical procedures (radio frequency skin tightening, non-surgical liposuction, chemical peel, high-intensity focused electromagnetic field, radio frequency fat removal), and practitioners may utilize a combination of both.

This report studies the Aesthetics market; it mainly covers the Aesthetics products for face, full body or other body parts. Mainly covers the Dermal Fillers, Botulinum Toxin, Breast Implants, Cosmetic Surgery Device and Others.

Selected research

Market Outlook & Growth Opportunities

Global Medical Aesthetics Market Outlook and Growth Opportunities 2026

28 December 2025191 pages

Choose your research edition.

Industry ResearchMedical Aesthetics Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Aesthetics Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Medical Aesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Aesthetics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Aesthetics Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Aesthetic medicine is an extensively broad term for specialties that focus on improving cosmetic appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, skin discoloration, and spider veins. Traditionally, aesthetic medicine includes dermatology, oral and maxillofacial surgery, reconstructive surgery and plastic surgery. Aesthetic medicine includes both surgical procedures (liposuction, facelifts, breast implants, Radio frequency ablation) and non-surgical procedures (radio frequency skin tightening, non-surgical liposuction, chemical peel, high-intensity focused electromagnetic field, radio frequency fat removal), and practitioners may utilize a combination of both.

This report studies the Aesthetics market; it mainly covers the Aesthetics products for face, full body or other body parts. Mainly covers the Dermal Fillers, Botulinum Toxin, Breast Implants, Cosmetic Surgery Device and Others.

Market competition is intense. Allergan, Galderma, LG Life Science, Merz Aesthetics, Ipsen, Syneron Medical, etc. are the leaders of the industry, with high-end customers.

Read the full market overview

This report provides an overview of the global Medical Aesthetics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Aesthetics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Aesthetics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Aesthetics market.

Medical Aesthetics Segment by Company

Allergan

Galderma

LG Life Science

Merz Aesthetics

Ipsen

Syneron Medical

Cynosure

Mentor Worldwide

Medytox

Valeant Pharmaceuticals

Fosun Pharma

Teoxane

Bloomage

GC Aesthetics

Suneva Medical

Medical Aesthetics Segment by Type

Dermal Fillers

Botulinum Toxin

Breast Implants

Cosmetic Surgery Device

Others

Medical Aesthetics Segment by Application

Facial Injectable

Fat Reduction

Breast Implant

Others

Medical Aesthetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Aesthetics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Aesthetics key companies, revenue, market share, and recent developments.

3. To split the Medical Aesthetics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Aesthetics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Aesthetics significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Aesthetics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Aesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Aesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Aesthetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Aesthetics industry.

Chapter 3: Detailed analysis of Medical Aesthetics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Aesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Aesthetics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Aesthetics Industry Trends Table 2. Medical Aesthetics Industry Drivers Table 3. Medical Aesthetics Industry Opportunities and Challenges Table 4. Medical Aesthetics Industry Restraints Table 5. Global Medical Aesthetics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Aesthetics Revenue Share by Company (2021-2026) Table 7. Global Medical Aesthetics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Aesthetics Key Company Manufacturing Base & Headquarters Table 9. Global Medical Aesthetics Company, Product Type & Application Table 10. Global Medical Aesthetics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Aesthetics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Dermal Fillers Table 15. Significant Companies of Botulinum Toxin Table 16. Significant Companies of Breast Implants Table 17. Significant Companies of Cosmetic Surgery Device Table 18. Significant Companies of Others Table 19. Global Medical Aesthetics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Medical Aesthetics Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Medical Aesthetics Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Medical Aesthetics Sales Value Share by Type (2021-2026) Table 23. Global Medical Aesthetics Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Facial Injectable Table 25. Significant Companies of Fat Reduction Table 26. Significant Companies of Breast Implant Table 27. Significant Companies of Others Table 28. Global Medical Aesthetics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Medical Aesthetics Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Medical Aesthetics Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Medical Aesthetics Sales Value Share by Application (2021-2026) Table 32. Global Medical Aesthetics Sales Value Share by Application (2027-2032) Table 33. Global Medical Aesthetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Medical Aesthetics Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Medical Aesthetics Sales Value Share by Region (2021-2026) Table 36. Global Medical Aesthetics Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Medical Aesthetics Sales Value Share by Region (2027-2032) Table 38. Global Medical Aesthetics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Medical Aesthetics Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Medical Aesthetics Sales Value Market Share by Country (2021-2026) Table 41. Global Medical Aesthetics Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Medical Aesthetics Sales Value Market Share by Country (2027-2032) Table 43. Allergan Company Information Table 44. Allergan Business Overview Table 45. Allergan Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Allergan Medical Aesthetics Product Portfolio Table 47. Allergan Recent Development Table 48. Galderma Company Information Table 49. Galderma Business Overview Table 50. Galderma Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Galderma Medical Aesthetics Product Portfolio Table 52. Galderma Recent Development Table 53. LG Life Science Company Information Table 54. LG Life Science Business Overview Table 55. LG Life Science Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. LG Life Science Medical Aesthetics Product Portfolio Table 57. LG Life Science Recent Development Table 58. Merz Aesthetics Company Information Table 59. Merz Aesthetics Business Overview Table 60. Merz Aesthetics Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Merz Aesthetics Medical Aesthetics Product Portfolio Table 62. Merz Aesthetics Recent Development Table 63. Ipsen Company Information Table 64. Ipsen Business Overview Table 65. Ipsen Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Ipsen Medical Aesthetics Product Portfolio Table 67. Ipsen Recent Development Table 68. Syneron Medical Company Information Table 69. Syneron Medical Business Overview Table 70. Syneron Medical Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Syneron Medical Medical Aesthetics Product Portfolio Table 72. Syneron Medical Recent Development Table 73. Cynosure Company Information Table 74. Cynosure Business Overview Table 75. Cynosure Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Cynosure Medical Aesthetics Product Portfolio Table 77. Cynosure Recent Development Table 78. Mentor Worldwide Company Information Table 79. Mentor Worldwide Business Overview Table 80. Mentor Worldwide Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mentor Worldwide Medical Aesthetics Product Portfolio Table 82. Mentor Worldwide Recent Development Table 83. Medytox Company Information Table 84. Medytox Business Overview Table 85. Medytox Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Medytox Medical Aesthetics Product Portfolio Table 87. Medytox Recent Development Table 88. Valeant Pharmaceuticals Company Information Table 89. Valeant Pharmaceuticals Business Overview Table 90. Valeant Pharmaceuticals Medical Aesthetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Valeant Pharmaceuticals Medical Aesthetics Product Portfolio Table 92. Valeant Pharmaceuticals Recent Development Table 93. Fosun Pharma Company Information Table 94. Fosun Pharma Business Overview Table 95. Fosun Pharma Medical Aesthetics Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 96. Fosun Pharma Medical Aesthetics Product Portfolio Table 97. Fosun Pharma Recent Development Table 98. Teoxane Company Information Table 99. Teoxane Business Overview Table 100. Teoxane Medical Aesthetics Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 101. Teoxane Medical Aesthetics Product Portfolio Table 102. Teoxane Recent Development Table 103. Bloomage Company Information Table 104. Bloomage Business Overview Table 105. Bloomage Medical Aesthetics Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 106. Bloomage Medical Aesthetics Product Portfolio Table 107. Bloomage Recent Development Table 108. GC Aesthetics Company Information Table 109. GC Aesthetics Business Overview Table 110. GC Aesthetics Medical Aesthetics Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 111. GC Aesthetics Medical Aesthetics Product Portfolio Table 112. GC Aesthetics Recent Development Table 113. Suneva Medical Company Information Table 114. Suneva Medical Business Overview Table 115. Suneva Medical Medical Aesthetics Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 116. Suneva Medical Medical Aesthetics Product Portfolio Table 117. Suneva Medical Recent Development Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Medical Aesthetics Product Image Figure 2. Global Medical Aesthetics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Aesthetics Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Aesthetics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Dermal Fillers Image Figure 8. Botulinum Toxin Image Figure 9. Breast Implants Image Figure 10. Cosmetic Surgery Device Image Figure 11. Others Image Figure 12. Global Medical Aesthetics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Medical Aesthetics Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Medical Aesthetics Sales Value Share by Type (2021-2032) Figure 15. Facial Injectable Image Figure 16. Fat Reduction Image Figure 17. Breast Implant Image Figure 18. Others Image Figure 19. Global Medical Aesthetics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Medical Aesthetics Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Medical Aesthetics Sales Value Share by Application (2021-2032) Figure 22. Global Medical Aesthetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Medical Aesthetics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Medical Aesthetics Sales Value (2021-2032) & (US$ Million) Figure 25. North America Medical Aesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Medical Aesthetics Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Medical Aesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Medical Aesthetics Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Medical Aesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Medical Aesthetics Sales Value (2021-2032) & (US$ Million) Figure 31. South America Medical Aesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Medical Aesthetics Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Medical Aesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Medical Aesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Medical Aesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Medical Aesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Dermal Fillers
  • Botulinum Toxin
  • Breast Implants
  • Cosmetic Surgery Device
  • Others
Applications
  • Facial Injectable
  • Fat Reduction
  • Breast Implant
  • Others
Companies covered
  • Allergan
  • Galderma
  • LG Life Science
  • Merz Aesthetics
  • Ipsen
  • Syneron Medical
  • Cynosure
  • Mentor Worldwide
  • Medytox
  • Valeant Pharmaceuticals
  • Fosun Pharma
  • Teoxane
  • Bloomage
  • GC Aesthetics
  • Suneva Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Aesthetics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Aesthetics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Aesthetics Market Dynamics
  1. 2.1 Medical Aesthetics Industry Trends
  2. 2.2 Medical Aesthetics Industry Drivers
  3. 2.3 Medical Aesthetics Industry Opportunities and Challenges
  4. 2.4 Medical Aesthetics Industry Restraints
3 Medical Aesthetics Market by Company
  1. 3.1 Global Medical Aesthetics Company Revenue Ranking in 2025
  2. 3.2 Global Medical Aesthetics Revenue by Company (2021-2026)
  3. 3.3 Global Medical Aesthetics Company Ranking (2024-2026)
  4. 3.4 Global Medical Aesthetics Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Aesthetics Company Product Type and Application
  6. 3.6 Global Medical Aesthetics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Aesthetics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Aesthetics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Aesthetics Market by Type
  1. 4.1 Medical Aesthetics Type Introduction
  2. 4.1.1 Dermal Fillers
  3. 4.1.2 Botulinum Toxin
  4. 4.1.3 Breast Implants
  5. 4.1.4 Cosmetic Surgery Device
  6. 4.1.5 Others
  7. 4.2 Global Medical Aesthetics Sales Value by Type
  8. 4.2.1 Global Medical Aesthetics Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Medical Aesthetics Sales Value by Type (2021-2032)
  10. 4.2.3 Global Medical Aesthetics Sales Value Share by Type (2021-2032)
5 Medical Aesthetics Market by Application
  1. 5.1 Medical Aesthetics Application Introduction
  2. 5.1.1 Facial Injectable
  3. 5.1.2 Fat Reduction
  4. 5.1.3 Breast Implant
  5. 5.1.4 Others
  6. 5.2 Global Medical Aesthetics Sales Value by Application
  7. 5.2.1 Global Medical Aesthetics Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Medical Aesthetics Sales Value by Application (2021-2032)
  9. 5.2.3 Global Medical Aesthetics Sales Value Share by Application (2021-2032)
6 Medical Aesthetics Regional Value Analysis
  1. 6.1 Global Medical Aesthetics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Aesthetics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Aesthetics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Aesthetics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Aesthetics Sales Value (2021-2032)
  7. 6.3.2 North America Medical Aesthetics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Aesthetics Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Aesthetics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Aesthetics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Aesthetics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Aesthetics Sales Value (2021-2032)
  16. 6.6.2 South America Medical Aesthetics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Aesthetics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Aesthetics Sales Value Share by Country, 2025 VS 2032
7 Medical Aesthetics Country-level Value Analysis
  1. 7.1 Global Medical Aesthetics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Aesthetics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Aesthetics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Aesthetics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Aesthetics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Aesthetics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Aesthetics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Aesthetics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Aesthetics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Aesthetics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Aesthetics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Aesthetics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Aesthetics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Aesthetics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Aesthetics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Aesthetics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Aesthetics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Aesthetics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Aesthetics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Aesthetics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Aesthetics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Aesthetics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Aesthetics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Aesthetics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Aesthetics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Aesthetics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Aesthetics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Aesthetics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Aesthetics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Aesthetics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Aesthetics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Aesthetics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Aesthetics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Aesthetics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Allergan
  2. 8.1.1 Allergan Company Information
  3. 8.1.2 Allergan Business Overview
  4. 8.1.3 Allergan Medical Aesthetics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Allergan Medical Aesthetics Product Portfolio
  6. 8.1.5 Allergan Recent Developments
  7. 8.2 Galderma
  8. 8.2.1 Galderma Company Information
  9. 8.2.2 Galderma Business Overview
  10. 8.2.3 Galderma Medical Aesthetics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Galderma Medical Aesthetics Product Portfolio
  12. 8.2.5 Galderma Recent Developments
  13. 8.3 LG Life Science
  14. 8.3.1 LG Life Science Company Information
  15. 8.3.2 LG Life Science Business Overview
  16. 8.3.3 LG Life Science Medical Aesthetics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 LG Life Science Medical Aesthetics Product Portfolio
  18. 8.3.5 LG Life Science Recent Developments
  19. 8.4 Merz Aesthetics
  20. 8.4.1 Merz Aesthetics Company Information
  21. 8.4.2 Merz Aesthetics Business Overview
  22. 8.4.3 Merz Aesthetics Medical Aesthetics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merz Aesthetics Medical Aesthetics Product Portfolio
  24. 8.4.5 Merz Aesthetics Recent Developments
  25. 8.5 Ipsen
  26. 8.5.1 Ipsen Company Information
  27. 8.5.2 Ipsen Business Overview
  28. 8.5.3 Ipsen Medical Aesthetics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ipsen Medical Aesthetics Product Portfolio
  30. 8.5.5 Ipsen Recent Developments
  31. 8.6 Syneron Medical
  32. 8.6.1 Syneron Medical Company Information
  33. 8.6.2 Syneron Medical Business Overview
  34. 8.6.3 Syneron Medical Medical Aesthetics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Syneron Medical Medical Aesthetics Product Portfolio
  36. 8.6.5 Syneron Medical Recent Developments
  37. 8.7 Cynosure
  38. 8.7.1 Cynosure Company Information
  39. 8.7.2 Cynosure Business Overview
  40. 8.7.3 Cynosure Medical Aesthetics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cynosure Medical Aesthetics Product Portfolio
  42. 8.7.5 Cynosure Recent Developments
  43. 8.8 Mentor Worldwide
  44. 8.8.1 Mentor Worldwide Company Information
  45. 8.8.2 Mentor Worldwide Business Overview
  46. 8.8.3 Mentor Worldwide Medical Aesthetics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mentor Worldwide Medical Aesthetics Product Portfolio
  48. 8.8.5 Mentor Worldwide Recent Developments
  49. 8.9 Medytox
  50. 8.9.1 Medytox Company Information
  51. 8.9.2 Medytox Business Overview
  52. 8.9.3 Medytox Medical Aesthetics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medytox Medical Aesthetics Product Portfolio
  54. 8.9.5 Medytox Recent Developments
  55. 8.10 Valeant Pharmaceuticals
  56. 8.10.1 Valeant Pharmaceuticals Company Information
  57. 8.10.2 Valeant Pharmaceuticals Business Overview
  58. 8.10.3 Valeant Pharmaceuticals Medical Aesthetics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Valeant Pharmaceuticals Medical Aesthetics Product Portfolio
  60. 8.10.5 Valeant Pharmaceuticals Recent Developments
  61. 8.11 Fosun Pharma
  62. 8.11.1 Fosun Pharma Company Information
  63. 8.11.2 Fosun Pharma Business Overview
  64. 8.11.3 Fosun Pharma Medical Aesthetics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fosun Pharma Medical Aesthetics Product Portfolio
  66. 8.11.5 Fosun Pharma Recent Developments
  67. 8.12 Teoxane
  68. 8.12.1 Teoxane Company Information
  69. 8.12.2 Teoxane Business Overview
  70. 8.12.3 Teoxane Medical Aesthetics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teoxane Medical Aesthetics Product Portfolio
  72. 8.12.5 Teoxane Recent Developments
  73. 8.13 Bloomage
  74. 8.13.1 Bloomage Company Information
  75. 8.13.2 Bloomage Business Overview
  76. 8.13.3 Bloomage Medical Aesthetics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bloomage Medical Aesthetics Product Portfolio
  78. 8.13.5 Bloomage Recent Developments
  79. 8.14 GC Aesthetics
  80. 8.14.1 GC Aesthetics Company Information
  81. 8.14.2 GC Aesthetics Business Overview
  82. 8.14.3 GC Aesthetics Medical Aesthetics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 GC Aesthetics Medical Aesthetics Product Portfolio
  84. 8.14.5 GC Aesthetics Recent Developments
  85. 8.15 Suneva Medical
  86. 8.15.1 Suneva Medical Company Information
  87. 8.15.2 Suneva Medical Business Overview
  88. 8.15.3 Suneva Medical Medical Aesthetics Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Suneva Medical Medical Aesthetics Product Portfolio
  90. 8.15.5 Suneva Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst